A sensitive blood test for neurofilament light chain (NF-L) protein may soon make it possible for primary care physicians to accurately distinguish Parkinson's disease from atypical parkinsonian disorders—even in the early stages of disease, a new study suggests.
Trending:
Blood Test Matches Spinal Tap to ID Parkinson Disease Types